EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Efficient Synthesis of a 1,3-Dioxolan-4-one-Based Impurity of Allisartan Isoproxil

Zhihao Du, Xin Gao, Tengyu Zhang, Dongsheng Chen, Yu Liu

Pharmaceutical Fronts · 01.09.2026 · 08 (03) · e230-e238

DOI: 10.1055/a-2929-2068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Fronts, erschienen am 01.09.2026. Verfasst von Zhihao Du und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is closely associated with aberrant activation of the renin–angiotensin system. Allisartan isoproxil, a prodrug angiotensin II receptor blocker, exhibits improved pharmacokinetic stability and medication safety compared with agents that rely on CYP450-mediated metabolism. However, multiple process-related impurities are inevitably generated during the industrial synthesis of allisartan isoproxil. Among its impurity profile, Impurity V is particularly noteworthy because of its unique 1,3-dioxolan-4-one structure. As a typical process-related impurity, it cannot be readily accessed through simple chemical transformations. The aim of this study is to establish an efficient synthetic route to Impurity V for the first time. Starting from N-benzylimidazole, we designed and developed a novel 13-step synthetic route to the target product. A key intramolecular cyclization catalyzed by I2 under mild conditions enabled the efficient construction of the imidazo-fused 1,3-dioxolane lactone core in 57% yield while effectively suppressing the undesired decarboxylation side reaction. Furthermore, optimization of the C5 chlorination step using a dimethyl sulfoxide/NaHCO3/CHCl3 system significantly improved the yield from 36 to 81%. Impurity V was subsequently obtained through sequential multistep oxidation, alkylation, and deprotection reactions. This route enabled the 10-g scale preparation of Impurity V with an overall yield of 3.6%. This work provides a practical synthetic route to an unstable lactone system and delivers a reliable reference standard for analytical method development, thereby supporting quality control and regulatory submission of allisartan isoproxil.

Zitieren

APA

Du, Z., Gao, X., Zhang, T., Chen, D., & Liu, Y. (2026). An Efficient Synthesis of a 1,3-Dioxolan-4-one-Based Impurity of Allisartan Isoproxil. Pharmaceutical Fronts, 08(03), e230-e238. https://doi.org/10.1055/a-2929-2068

Vancouver

Du Z, Gao X, Zhang T, Chen D, Liu Y. An Efficient Synthesis of a 1,3-Dioxolan-4-one-Based Impurity of Allisartan Isoproxil. Pharmaceutical Fronts. 2026;08(03):e230-e238. doi:10.1055/a-2929-2068

BibTeX
@article{Du2026,
  author = {Du, Zhihao and Gao, Xin and Zhang, Tengyu and Chen, Dongsheng and Liu, Yu},
  title = {An Efficient Synthesis of a 1,3-Dioxolan-4-one-Based Impurity of Allisartan Isoproxil},
  journal = {Pharmaceutical Fronts},
  year = {2026},
  volume = {08},
  number = {03},
  pages = {e230--e238},
  doi = {10.1055/a-2929-2068}
}
Kostenlos starten →